ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Massachusetts » Internal Medicine

Top Internal Medicine Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
IRINA SKURLATOVA-MAYSKY M.D.

Internal Medicine

15,980

$816K

327
317 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $56

PHILIP TAVANO M.D.

Internal Medicine

15,827

$883K

722
627 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $56

BESSIE HAZARD MD

Internal Medicine

15,805

$697K

332
328 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $56

EDWARD KAMENS M.D.

Internal Medicine

15,629

$902K

647
576 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $56

ESMAIL FALLAH SOHY MD

Internal Medicine

15,503

$697K

352
330 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $56

RAMON ESPINOSA M.D.

Internal Medicine

15,400

$848K

447
380 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $56

MITCHELL ABRAMSON M.D.

Internal Medicine

15,322

$694K

452
395 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $56

ANDREW LEVIN M.D.

Internal Medicine

15,164

$652K

360
303 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$43
Average prescription price

Avg: $56

LORENVER PO MD

Internal Medicine

15,153

$806K

815
478 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $56

ALLAN ENGEL M.D.

Internal Medicine

15,106

$772K

410
393 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $56

ELIAS NAME MD

Internal Medicine

15,016

$716K

755
425 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $56

GEORGE MELTSAKOS M.D.

Internal Medicine

14,995

$949K

515
431 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $56

NEETI JHA M.D.

Internal Medicine

14,884

$650K

700
520 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $56

GEORGE DESPINES MD

Internal Medicine

14,867

$742K

588
461 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $56

JOHN PLATT MD

Internal Medicine

14,820

$671K

709
626 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $56

KENNETH AQUILINO MD

Internal Medicine

14,770

$985K

742
435 are 65+

17%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$67
Average prescription price

Avg: $56

IDA MINEVICH MD

Internal Medicine

14,689

$699K

301
281 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $56

DIANE PATRICK MD

Internal Medicine

14,621

$685K

406
320 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $56

PEDRO FALLA M.D.

Internal Medicine

14,560

$718K

503
243 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $56

RAVINDER SOODAN MD

Internal Medicine

14,527

$707K

407
301 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $56

VINAY KUMAR MD

Internal Medicine

14,454

$931K

683
538 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $56

CARL SOUSA M.D.

Internal Medicine

14,445

$634K

429
359 are 65+

17%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $56

MIN SONG MD

Internal Medicine

14,407

$794K

379
349 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $56

SIDERIS BAER M.D.

Internal Medicine

14,369

$598K

437
357 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $56

PAULA CARMICHAEL MD

Internal Medicine

14,306

$699K

299
287 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank